Studies have confirmed that HHLA2 is highly expressed in most malignant tumor tissues, including breast cancer, lung cancer, thyroid cancer, melanoma and pancreas adenocarcinoma, ovarian cancer, liver cancer, bladder cancer, colon cancer, prostate cancer, kidney cancer, and esophageal cancer. The gene discussed is HHLA2; the disease is urinary bladder cancer.